Your team

Meet the Dull Skin Team

This site is led and medically reviewed by Tongchun Mao, MD, who is responsible for the medical content and for the assessment that decides whether a complexion problem is a surface problem at all. The other three contribute what that assessment often needs: the surface and laser perspective with an honest account of pigment risk, the dermatologic diagnosis of a pigment disorder or a damaged barrier, and the surgical view of a face whose real complaint is volume loss rather than surface.

Specialist profiles

Who reviews this content

Tongchun Mao (毛彤春)

Deputy Director & Head of Aesthetic Surgery · Vice Chief Physician, Licensed Aesthetic Attending · Lead Physician of This Site

Aesthetic surgery · skin surface and tone · assessment of what a surface treatment can change

Dr. Tongchun Mao is an aesthetic surgeon at Chongqing West District Hospital, where he is Deputy Director and Head of Aesthetic Surgery in its Plastic Surgery & Aesthetics Medical Center and the responsible physician for this site. He personally performs more than 700 operations a year, within hospital standards of assessment, anaesthesia and follow-up.

On this site his part is the assessment that decides whether a complexion problem is a surface problem at all. Most of the faces he sees for dullness are dehydrated, over-exfoliated, or carrying pigment that has never been diagnosed, and his first move is to establish which of those is present before anything is offered. He is direct about the ceiling: the surface can be changed and the change can be held, but no treatment makes skin permanently luminous, and a patient whose real complaint is volume loss or descent is told that a surface treatment will not answer it.

Clinical focus

Assessment of whether a complexion complaint is a surface problem or something else
Telling pigment patterns apart, and which of them must not be treated as cosmetic
When the honest answer is barrier care rather than an in-clinic session
The limits of peels, light-based sessions and topical agents, stated before they are offered
Recognising the findings that belong with a physician rather than with a skincare routine

Maintenance, not correction

Dullness is not a defect that gets repaired and stays repaired. Turnover continues, oil returns and ultraviolet exposure continues, which is why a result that is not held up by daily care fades within months. That is not a failure of the treatment; it is what the skin does, and a plan that does not say so in advance is a plan that will end in disappointment.

Shaoliang Wang (王韶亮)

Director, Plastic Surgery & Aesthetics Medical Center · Vice Chief Physician, Associate Professor, Doctor of Medicine

Center leadership · surgical standards and complex assessment

Dr. Shaoliang Wang is Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team he provides the surgical perspective and the tertiary-hospital backstop — the assessment when an operation is the honest answer, and the hospital-level care for the rare complication that needs it.

Within this site his part is the case that is not a surface problem at all: a complexion that looks tired because of volume loss, descent or a medical condition, and that needs a physician’s assessment rather than another product or session.

Clinical focus

Center leadership and multidisciplinary case review
Surgical assessment when an operation is the honest answer to descent or excess skin
Hospital-based care for the rare complication that needs theatre-level management

Ke He (何锞)

Deputy Director & Head of Skin & Laser Aesthetics · Attending Physician, Licensed Aesthetic Attending

Skin and laser aesthetics · surface treatments and pigment risk

Dr. Ke He is Deputy Director and head of skin and laser aesthetics within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team her role is the device and injectable assessment, and the honest referral when a problem needs an operation rather than a needle.

Within this site her part is what an in-clinic session can and cannot do for a surface, and how much pigment risk a given skin tone carries. She is the person who says when the daily rungs are the whole answer and a course of sessions would be wasted.

Clinical focus

Device and injectable assessment before any treatment plan
Staged planning judged against standardised photographs
Honest referral when a problem needs an operation rather than a needle

Yongbo Jia (贾勇波)

Deputy Director & Head of Dermatology · Vice Chief Physician, Licensed Aesthetic Attending

Dermatology · pigment disorders and barrier disease

Dr. Yongbo Jia is a dermatologist within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is medical skin assessment — diagnosing and managing pigment and barrier conditions, and treating skin that a device or an injection has irritated.

Within this site his part is the complexion that is uneven because of a diagnosable pigment disorder, an inflammatory condition or a barrier that has been damaged by over-treatment — the cases where the answer is a diagnosis and prescription management rather than a cosmetic plan.

Clinical focus

Medical skin assessment behind injectable treatment plans
Diagnosis and management of pigment and barrier conditions
Dermatologic care of skin after irritation or a delayed reaction

Start with an assessment, not a package

Arrange a consultation. We will establish which contributor is behind the dullness, explain what treatment can and cannot change for your skin, and set out the options including doing nothing.

Contact the Team